LSL Pharma Group Inc. (TSXV:LSL)

Canada · Delayed Price · Currency is CAD

0.5200

0.00 (0.00%)

At close: Feb 9, 2026

Revenue by Product

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Contract Manufacturing	10.54M
Eye-Care	7.21M

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Canada	17.75M
Canada Growth	76.98%